Silvestro Stephen L, CEO of OptimizeRx Corp ($OPRX), made one open market sale of shares in the last year, totaling $30,375, with the most recent on October 3, 2025. He ranks 10,815th out of 11,678 insiders for sales volume, well below the average of $8.6 million across 6.4 transactions. No open market purchases recorded.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec. 23, 2025 | OptimizeRx Corp | $OPRX | Silvestro Stephen L | Chief Executive Officer | F | Common Stock | 3361 | $12.74 | 190,507.0000 | 20,333,839 | 1.73% | 0.02% |
| Dec. 23, 2025 | OptimizeRx Corp | $OPRX | Silvestro Stephen L | Chief Executive Officer | F | Common Stock | 3361 | $12.74 | 190,507.0000 | 20,333,839 | 1.73% | 0.02% |
| Dec. 19, 2025 | OptimizeRx Corp | $OPRX | Silvestro Stephen L | Chief Executive Officer | M | Common Stock | 6546 | $0.00 | 195,462.0000 | 20,333,839 | 3.47% | 0.03% |
| Dec. 19, 2025 | OptimizeRx Corp | $OPRX | Silvestro Stephen L | Chief Executive Officer | M | Restricted Stock Units | 6546 | $0.00 | 6,547.0000 | 20,333,839 | 50.00% | 0.03% |
| Dec. 19, 2025 | OptimizeRx Corp | $OPRX | Silvestro Stephen L | Chief Executive Officer | F | Common Stock | 1594 | $13.51 | 193,868.0000 | 20,333,839 | 0.82% | 0.01% |
| Oct. 3, 2025 | OptimizeRx Corp | $OPRX | Silvestro Stephen L | Chief Executive Officer | M | Common Stock | 6649 | $0.00 | 190,536.0000 | 20,333,839 | 3.62% | 0.03% |
| Oct. 3, 2025 | OptimizeRx Corp | $OPRX | Silvestro Stephen L | Chief Executive Officer | M | Restricted Stock Units | 6649 | $0.00 | 0.0000 | 20,333,839 | 100.00% | 0.03% |
| Oct. 3, 2025 | OptimizeRx Corp | $OPRX | Silvestro Stephen L | Chief Executive Officer | S | Common Stock | 1620 | $18.75 | 188,916.0000 | 20,333,839 | 0.85% | 0.01% |
| Aug. 21, 2025 | OptimizeRx Corp | $OPRX | Silvestro Stephen L | Chief Executive Officer | A | Stock Option | 35156 | $0.00 | 35,156.0000 | 20,297,388 | 9999.99% | 0.17% |
| Aug. 21, 2025 | OptimizeRx Corp | $OPRX | Silvestro Stephen L | Chief Executive Officer | A | Common Stock | 15625 | $0.00 | 183,887.0000 | 20,297,388 | 9.29% | 0.08% |
| May 15, 2025 | OptimizeRx Corp | $OPRX | Silvestro Stephen L | Chief Commercial Officer | A | Stock Option | 80884 | $0.00 | 80,884.0000 | 20,234,186 | 9999.99% | 0.40% |
| May 15, 2025 | OptimizeRx Corp | $OPRX | Silvestro Stephen L | Chief Commercial Officer | A | Common Stock | 46948 | $0.00 | 168,262.0000 | 20,234,186 | 38.70% | 0.23% |
| March 1, 2025 | OptimizeRx Corp | $OPRX | Silvestro Stephen L | Chief Commercial Officer | M | Restricted Stock Units | 1928 | $0.00 | 0.0000 | 20,194,697 | 100.00% | 0.01% |
| March 1, 2025 | OptimizeRx Corp | $OPRX | Silvestro Stephen L | Chief Commercial Officer | F | Common Stock | 572 | $5.18 | 121,314.0000 | 20,194,697 | 0.47% | 0.00% |
| March 1, 2025 | OptimizeRx Corp | $OPRX | Silvestro Stephen L | Chief Commercial Officer | M | Common Stock | 1928 | $0.00 | 121,886.0000 | 20,194,697 | 1.61% | 0.01% |
| Feb. 15, 2025 | OptimizeRx Corp | $OPRX | Silvestro Stephen L | Chief Commercial Officer | F | Common Stock | 2298 | $6.64 | 119,958.0000 | 20,194,697 | 1.88% | 0.01% |
| Dec. 23, 2024 | OptimizeRx Corp | $OPRX | Silvestro Stephen L | Chief Commercial Officer | A | Common Stock | 41408 | $0.00 | 122,256.0000 | 20,069,432 | 51.22% | 0.21% |
| Dec. 23, 2024 | OptimizeRx Corp | $OPRX | Silvestro Stephen L | Chief Commercial Officer | A | Stock Option | 77742 | $0.00 | 77,742.0000 | 20,069,432 | 9999.99% | 0.39% |
| Dec. 19, 2024 | OptimizeRx Corp | $OPRX | Silvestro Stephen L | Chief Commercial Officer | F | Common Stock | 2576 | $4.75 | 80,848.0000 | 20,069,432 | 3.09% | 0.01% |
| Dec. 19, 2024 | OptimizeRx Corp | $OPRX | Silvestro Stephen L | Chief Commercial Officer | M | Common Stock | 6546 | $0.00 | 83,424.0000 | 20,069,432 | 8.51% | 0.03% |
| Dec. 19, 2024 | OptimizeRx Corp | $OPRX | Silvestro Stephen L | Chief Commercial Officer | M | Restricted Stock Units | 6546 | $0.00 | 13,093.0000 | 20,069,432 | 33.33% | 0.03% |
| Oct. 3, 2024 | OptimizeRx Corp | $OPRX | Silvestro Stephen L | Chief Commercial Officer | F | Common Stock | 2617 | $7.83 | 76,878.0000 | 20,069,432 | 3.29% | 0.01% |
| Oct. 3, 2024 | OptimizeRx Corp | $OPRX | Silvestro Stephen L | Chief Commercial Officer | M | Common Stock | 6649 | $0.00 | 79,495.0000 | 20,069,432 | 9.13% | 0.03% |
| Oct. 3, 2024 | OptimizeRx Corp | $OPRX | Silvestro Stephen L | Chief Commercial Officer | M | Restricted Stock Units | 6649 | $0.00 | 6,649.0000 | 20,069,432 | 50.00% | 0.03% |
| May 2, 2024 | OptimizeRx Corp | $OPRX | Silvestro Stephen L | Chief Commercial Officer | M | Restricted Stock Units | 90000 | $0.00 | 0.0000 | 19,921,879 | 100.00% | 0.45% |
| March 1, 2024 | OptimizeRx Corp | $OPRX | Silvestro Stephen L | Chief Commercial Officer | M | Common Stock | 1927 | $0.00 | 18,833.0000 | 19,899,679 | 11.40% | 0.01% |
| March 1, 2024 | OptimizeRx Corp | $OPRX | Silvestro Stephen L | Chief Commercial Officer | F | Common Stock | 572 | $15.95 | 18,261.0000 | 19,899,679 | 3.04% | 0.00% |
| Feb. 15, 2024 | OptimizeRx Corp | $OPRX | Silvestro Stephen L | Chief Commercial Officer | A | Common Stock | 7750 | $0.00 | 16,906.0000 | 19,899,679 | 84.64% | 0.04% |
| May 2, 2024 | OptimizeRx Corp | $OPRX | Silvestro Stephen L | Chief Commercial Officer | F | Common Stock | 35415 | $10.70 | 72,846.0000 | 19,921,879 | 32.71% | 0.18% |
| May 2, 2024 | OptimizeRx Corp | $OPRX | Silvestro Stephen L | Chief Commercial Officer | M | Common Stock | 90000 | $0.00 | 108,261.0000 | 19,921,879 | 492.85% | 0.45% |
| March 15, 2024 | OptimizeRx Corp | $OPRX | Silvestro Stephen L | Chief Commercial Officer | A | Common Stock | 7750 | $0.00 | 13,706.0000 | 19,899,679 | 130.12% | 0.04% |
| March 1, 2024 | OptimizeRx Corp | $OPRX | Silvestro Stephen L | Chief Commercial Officer | M | Restricted Stock Units | 1927 | $0.00 | 1,928.0000 | 19,899,679 | 49.99% | 0.01% |
| March 1, 2024 | OptimizeRx Corp | $OPRX | Silvestro Stephen L | Chief Commercial Officer | F | Common Stock | 668 | $15.95 | 5,956.0000 | 19,899,679 | 10.08% | 0.00% |
| March 1, 2024 | OptimizeRx Corp | $OPRX | Silvestro Stephen L | Chief Commercial Officer | M | Common Stock | 1927 | $0.00 | 6,624.0000 | 19,899,679 | 41.03% | 0.01% |
| Dec. 19, 2023 | OptimizeRx Corp | $OPRX | Silvestro Stephen L | Chief Commercial Officer | A | Stock Option | 19639 | $0.00 | 19,639.0000 | 0 | 9999.99% | 0.00% |
| Dec. 19, 2023 | OptimizeRx Corp | $OPRX | Silvestro Stephen L | Chief Commercial Officer | A | Restricted Stock Units | 19639 | $0.00 | 19,639.0000 | 0 | 9999.99% | 0.00% |
| Oct. 3, 2023 | OptimizeRx Corp | $OPRX | Silvestro Stephen L | Chief Commercial Officer | F | Common Stock | 1952 | $7.06 | 4,697.0000 | 0 | 29.36% | 0.00% |
| Oct. 3, 2023 | OptimizeRx Corp | $OPRX | Silvestro Stephen L | Chief Commercial Officer | M | Restricted Stock Units | 6649 | $0.00 | 13,298.0000 | 0 | 33.33% | 0.00% |
| Oct. 3, 2023 | OptimizeRx Corp | $OPRX | Silvestro Stephen L | Chief Commercial Officer | M | Common Stock | 6649 | $0.00 | 6,649.0000 | 0 | 9999.99% | 0.00% |
| March 1, 2023 | OptimizeRx Corp | $OPRX | Silvestro Stephen L | Chief Commercial Officer | M | Common Stock | 1927 | $0.00 | 5,127.0000 | 0 | 60.22% | 0.00% |
| March 1, 2023 | OptimizeRx Corp | $OPRX | Silvestro Stephen L | Chief Commercial Officer | M | Restricted Stock Units | 1927 | $0.00 | 3,855.0000 | 0 | 33.33% | 0.00% |
| March 1, 2023 | OptimizeRx Corp | $OPRX | Silvestro Stephen L | Chief Commercial Officer | F | Common Stock | 668 | $18.11 | 4,459.0000 | 0 | 13.03% | 0.00% |